← Back to headlines
ImmunityBio's Global Expansion Drives 266% Stock Surge
ImmunityBio (IBRX) has seen its stock jump by 266% this year, a significant increase attributed to the company's global expansion efforts.
17 Apr, 11:26 — 17 Apr, 11:26
Sources
Showing 1 of 1 sources
